Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosisidiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorderNot yet recruitingPhase 32026-09-08NCT07520110

2 results · Page 1 of 1

Swipe the table sideways for more columns.

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Georgetown University HospitalWashington D.C.United States14
Massachusetts General HospitalBostonUnited States1015
Mayo ClinicRochesterUnited States664
Michael E. DeBakey VA Medical CenterHoustonUnited States18
Northwestern UniversityChicagoUnited States727
Temple UniversityPhiladelphiaUnited States50
University of ArizonaTucsonUnited States53
University of ChicagoChicagoUnited States312
University of Colorado AnschutzAuroraUnited States30
University of Massachusetts Chan Medical SchoolWorcesterUnited States33
University of MichiganAnn ArborUnited States538
University of Texas SouthwesternDallasUnited States73
University of UtahSalt Lake CityUnited States72
University of WashingtonSeattleUnited States172
Weill Cornell MedicineNew YorkUnited States1